Cellectis CLLS
NASDAQ CLLS
$1.47 -0.01 (-0.68%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cellectis (CLLS) Current Leases (2016 - 2023)

Updated

Cellectis' Current Leases came in at $8.39 million for Q4 2023, compared with $97,000 a year earlier.

Analysis

Cellectis (CLLS) Current Leases (2016 - 2023) Analysis & Trends

Going back to Q4 2016, Cellectis' Current Leases data covers 6 quarters.

  • Going back by year, Current Leases was $97,000 in FY2022 (-73.8%) and $370,000 in FY2021.
  • The Q4 2023 figure represents the highest quarterly Current Leases since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Cellectis 148.50 Mn -604.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 8.39 Mn
Dec 31, 2022 97,000.00
Mar 31, 2022 290,000.00
Dec 31, 2021 370,000.00
Dec 31, 2017 43.53 Mn
Dec 31, 2016 56.17 Mn
API Access

Cellectis Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CLLS&period=max&api_key=YOUR_API_KEY